Entering text into the input field will update the search result below

Biocatalyst developer Codexis (NASDAQ:CDXS) falls 12.9% AH after announcing CEO Alan Shaw has...

Feb. 17, 2012 5:06 PM ETCodexis, Inc. (CDXS) StockCDXSBy: Eric Jhonsa, SA News Editor
Biocatalyst developer Codexis (NASDAQ:CDXS) falls 12.9% AH after announcing CEO Alan Shaw has resigned to "pursue other interests." Peter Strumph, head of the company's pharmaceuticals division, will serve as interim CEO while the board searches for a full-time replacement. Codexis shares tumbled last week following the company's Q4 miss.

Recommended For You

More Trending News

About CDXS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CDXS--
Codexis, Inc.